Published in Ann Nutr Metab on November 18, 2016
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ (2009) 5.79
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med (2009) 2.67
Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests. Eur J Gastroenterol Hepatol (2006) 2.63
Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer (2003) 2.53
Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis (2010) 2.32
Cardiovascular disease prevention using fixed dose pharmacotherapy in Iran: updated meta-analyses and mortality estimation. Arch Iran Med (2012) 2.17
Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med (2007) 2.12
Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol (2009) 2.10
Opium use and risk of mortality from digestive diseases: a prospective cohort study. Am J Gastroenterol (2013) 2.07
Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran. BMJ (2012) 2.07
The gastro-esophageal malignancies in Northern Iran research project: impact on the health research and health care systems in Iran. Arch Iran Med (2013) 2.01
Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells. Stem Cell Rev (2010) 1.98
Esophageal cancer in Northeastern Iran: a review. Arch Iran Med (2007) 1.95
Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomarkers Prev (2004) 1.95
Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J Hypertens (2013) 1.86
Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008. Arch Iran Med (2012) 1.84
Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol (2009) 1.77
Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health (2006) 1.75
Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran. Gut (2010) 1.71
High prevalence of coeliac disease in apparently healthy Iranian blood donors. Eur J Gastroenterol Hepatol (2003) 1.69
Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Am J Clin Nutr (2014) 1.66
Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. Cancer Detect Prev (2006) 1.65
Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis. Liver Int (2013) 1.64
Healthy ranges of serum alanine aminotransferase levels in Iranian blood donors. World J Gastroenterol (2003) 1.63
Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998-2001. Arch Iran Med (2009) 1.59
Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World J Gastroenterol (2008) 1.59
Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. Arch Iran Med (2007) 1.58
High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. Anticancer Res (2005) 1.57
Prevalence of celiac disease among patients with Behcet's disease in Iran. Dig Dis Sci (2008) 1.54
Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry. Cancer Lett (2005) 1.53
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Coeliac disease in autoimmune liver disease: a cross-sectional study and a systematic review. Dig Liver Dis (2010) 1.49
Brain-derived neurotrophic factor predicts physical health in untreated patients with hepatitis C. Biol Psychiatry (2011) 1.49
Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2008) 1.47
Verbal autopsy: reliability and validity estimates for causes of death in the Golestan Cohort Study in Iran. PLoS One (2010) 1.47
Probucol in the treatment of nonalcoholic steatohepatitis: an open-labeled study. J Clin Gastroenterol (2003) 1.47
Ecologic study of serum selenium and upper gastrointestinal cancers in Iran. World J Gastroenterol (2004) 1.47
Surface area: a better predictor of disease severity than the height and volume of the barium column in patients with primary achalasia. Eur J Gastroenterol Hepatol (2006) 1.45
Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users. Hepat Mon (2011) 1.44
Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease. Am J Gastroenterol (2006) 1.41
Topography of gastritis and its severity in 864 first degree relatives of gastric cancer patients. Arch Iran Med (2010) 1.41
The Leaning Tower illusion: a new illusion of perspective. Perception (2007) 1.40
Polypill for prevention of cardiovascular diseases with focus on non-alcoholic steatohepatitis: the PolyIran-Liver trial. Eur Heart J (2022) 1.39
Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol (2007) 1.39
Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J Med Virol (2004) 1.38
A survey of the current status of web-based databases indexing Iranian journals. Arch Iran Med (2009) 1.35
Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med (2010) 1.35
Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer. World J Gastroenterol (2006) 1.30
Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. J Gastroenterol Hepatol (2005) 1.30
Epidemiologic characteristics of 500 patients with inflammatory bowel disease in Iran studied from 2004 through 2007. Arch Iran Med (2009) 1.28
Epidemiology of gastroesophageal reflux symptoms in Tehran, Iran: a population-based telephone survey. Arch Iran Med (2007) 1.27
Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran - a review. Eur J Cancer (2009) 1.27
The upper normal limit of serum alanine aminotransferase in Golestan Province, northeast Iran. Arch Iran Med (2008) 1.25
In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nucl Med Biol (2011) 1.22
The role of diet and other environmental factors in the causation of gastric cancer in Iran--a population based study. Int J Cancer (2009) 1.21
Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B. BMC Gastroenterol (2005) 1.21
Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World J Gastroenterol (2005) 1.21
Comparison of breast cancer survival in two populations: Ardabil, Iran and British Columbia, Canada. BMC Cancer (2009) 1.20
Diabetes mellitus and its correlates in an Iranian adult population. PLoS One (2011) 1.19
Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran. Int J Cancer (2006) 1.15
Helicobacter pylori endemic and gastric disease. Dig Dis Sci (2005) 1.15
Comparison of cancer incidence in Iran and Iranian immigrants to British Columbia, Canada. Asian Pac J Cancer Prev (2006) 1.13
Prognostic factors for esophageal squamous cell carcinoma--a population-based study in Golestan Province, Iran, a high incidence area. PLoS One (2011) 1.13
Hygiene could affect GERD prevalence independently: a population-based study in Tehran. Am J Gastroenterol (2007) 1.12
Seroprevalence of hepatitis B surface antigen and anti hepatitis C antibody in zahedan city, iran: a population-based study. Hepat Mon (2012) 1.11
Dietary intake of benzo(a)pyrene and risk of esophageal cancer in north of Iran. Nutr Cancer (2008) 1.11
InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers. J Natl Cancer Inst (2012) 1.09
Childhood hygienic practice and family education status determine the prevalence of Helicobacter pylori infection in Iran. Helicobacter (2009) 1.08
LRP6 enhances glucose metabolism by promoting TCF7L2-dependent insulin receptor expression and IGF receptor stabilization in humans. Cell Metab (2013) 1.08
Patterns of food and nutrient consumption in northern Iran, a high-risk area for esophageal cancer. Nutr Cancer (2009) 1.07
Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone. Hepatol Res (2006) 1.07
Opium: an emerging risk factor for gastric adenocarcinoma. Int J Cancer (2013) 1.06
Prevention of non-communicable diseases: what can be done? Arch Iran Med (2013) 1.06
p16INK4a hypermethylation and p53, p16 and MDM2 protein expression in esophageal squamous cell carcinoma. BMC Cancer (2010) 1.06
Reducing the burden of chronic diseases: a neglected agenda in Iranian health care system, requiring a plan for action. Arch Iran Med (2010) 1.04